Infinity Pharmaceuticals

Infinity Pharmaceuticals Book Value per Share

The Book Value per Share of Infinity Pharmaceuticals (INFIQ) as of Oct 10, 2026 is -0.21 USD. In the previous year, Book Value per Share was 0.24 USD — a change of -188.32% (lower).

Book Value per Share

-0.21USD

YoY

-188.32%

Last updated:

Book Value per Share of Infinity Pharmaceuticals is 2022 -0.21 USD. Book Value per Share of Infinity Pharmaceuticals was 2021 0.24 USD. It decreases by -188.32% lower compared to the previous year.

The Infinity Pharmaceuticals Book Value per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Book Value per Share
Date
Book Value per Share
Jan 1, 2015
1.09 USD
Jan 1, 2016
0.91 USD
Jan 1, 2017
0.53 USD
Jan 1, 2018
0.58 USD
Jan 1, 2019
0.09 USD
Jan 1, 2020
-0.25 USD
Jan 1, 2021
0.24 USD
Jan 1, 2022
-0.21 USD
The Infinity Pharmaceuticals Book Value per Share history
YEARBook Value per ShareYoY
-0.21USD-188.32%
0.24USD-193.83%
-0.25USD-397.55%
0.09USD-85.28%
0.58USD+10.06%
0.53USD-42.18%
0.91USD-16.33%
1.09USD-52.94%
2.31USD—
Access this data via the Eulerpool API
Get Free API Key

Infinity Pharmaceuticals Stock analysis

What does Infinity Pharmaceuticals do? Infinity Pharmaceuticals Inc. is a biopharmaceutical company based in Cambridge, Massachusetts. It was founded in 2001 and focuses on the discovery and development of novel therapies for cancer and other serious diseases. Infinity Pharmaceuticals is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Infinity Pharmaceuticals stock

Book Value per Share of Infinity Pharmaceuticals is -0.21 USD in 2022.

Book Value per Share of Infinity Pharmaceuticals changed from 0.24 USD to -0.21 USD, representing a -188.32% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Book Value per Share Infinity Pharmaceuticals since 2006 – with annual values, charts, and detailed analysis.

Book value per share represents the net asset value of the company per outstanding share. Comparing it to the stock price helps assess whether a stock is undervalued.

Access this data via the Eulerpool API
Get Free API Key

Balance Sheet — Infinity Pharmaceuticals

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Infinity Pharmaceuticals